12/17
04:08 pm
moln
Molecular Partners to Present at JP Morgan Healthcare Conference and Baader Helvea Swiss Equities Conference in January [Yahoo! Finance]
Low
Report
Molecular Partners to Present at JP Morgan Healthcare Conference and Baader Helvea Swiss Equities Conference in January [Yahoo! Finance]
12/17
04:00 pm
moln
Molecular Partners to Present at JP Morgan Healthcare Conference and Baader Helvea Swiss Equities Conference in January
Low
Report
Molecular Partners to Present at JP Morgan Healthcare Conference and Baader Helvea Swiss Equities Conference in January
12/8
12:00 pm
moln
Molecular Partners Presents Clinical Data Supporting its Ongoing MP0533 Study and Preclinical Data on Next-Gen Conditioning Agent MP0621 at ASH 2024
Low
Report
Molecular Partners Presents Clinical Data Supporting its Ongoing MP0533 Study and Preclinical Data on Next-Gen Conditioning Agent MP0621 at ASH 2024
11/7
04:00 pm
moln
Molecular Partners Presents Preclinical Proof-of-Concept for CD3 Switch-DARPin T Cell Engager, Clinical Biomarker Analyses for MP0317 at SITC 2024
Low
Report
Molecular Partners Presents Preclinical Proof-of-Concept for CD3 Switch-DARPin T Cell Engager, Clinical Biomarker Analyses for MP0317 at SITC 2024
11/5
04:00 pm
moln
Molecular Partners Announces Upcoming Poster Presentations at the 65th ASH Annual Meeting and Exposition
Medium
Report
Molecular Partners Announces Upcoming Poster Presentations at the 65th ASH Annual Meeting and Exposition
10/31
04:00 pm
moln
Molecular Partners Q3 2024 Interim Management Statement: Multiple Updates Across Portfolio, Radio-DARPin candidate MP0712 preparing for clinical entry, MP0533 Phase 1 on-going
High
Report
Molecular Partners Q3 2024 Interim Management Statement: Multiple Updates Across Portfolio, Radio-DARPin candidate MP0712 preparing for clinical entry, MP0533 Phase 1 on-going
10/25
01:14 am
moln
Molecular Partners Announces Pricing of $20 Million Underwritten Offering [Yahoo! Finance]
Medium
Report
Molecular Partners Announces Pricing of $20 Million Underwritten Offering [Yahoo! Finance]
10/25
01:00 am
moln
Molecular Partners Announces Pricing of $20 Million Underwritten Offering
Medium
Report
Molecular Partners Announces Pricing of $20 Million Underwritten Offering
10/31
04:01 pm
moln
Form 6-K MOLECULAR PARTNERS AG For: Sep 30
High
Report
Form 6-K MOLECULAR PARTNERS AG For: Sep 30
10/29
04:33 pm
moln
Form SC 13D/A MOLECULAR PARTNERS AG Filed by: BIOTECHNOLOGY VALUE FUND L P
Low
Report
Form SC 13D/A MOLECULAR PARTNERS AG Filed by: BIOTECHNOLOGY VALUE FUND L P
10/28
04:06 pm
moln
Form 6-K MOLECULAR PARTNERS AG For: Oct 28
Medium
Report
Form 6-K MOLECULAR PARTNERS AG For: Oct 28
10/25
09:20 am
moln
Form 424B5 MOLECULAR PARTNERS AG
Low
Report
Form 424B5 MOLECULAR PARTNERS AG
10/22
09:02 am
moln
Form 6-K MOLECULAR PARTNERS AG For: Oct 22
Medium
Report
Form 6-K MOLECULAR PARTNERS AG For: Oct 22
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register